“Subclinical Left Ventricular Dysfunction Prevention in Breast Cancer Patients after FAC Chemotherapy: A Carvedilol Trial” (2024) International Journal of Integrated Health Sciences, 12(1), pp. 55–64. doi:10.15850/ijihs.v12.n1.3570.